Report Overview:
The medical nasogastric tubes (NG and NJ) market pertains to the market for tubes inserted through the nasal cavity, advancing into the oesophagus and ultimately the stomach, primarily for nutritional or medical purposes. This process, known as Naso Gastric (NG) or Nasojejunal (NJ) feeding, is commonly used for individuals who are unable to consume food orally due to various medical conditions, such as swallowing difficulties, neurological disorders, or gastrointestinal diseases. The tubes are also employed for the administration of medications, fluids, and other therapies directly into the stomach or small intestine.
Nasogastric tubes come in various forms and materials, including polyurethane, silicone, and PVC, designed for specific patient needs. These tubes are mostly used in hospitals, healthcare facilities, and home care settings, playing a vital role in the nutritional management and medical treatment of patients.
Market Value:
The global market for medical nasogastric tubes was valued at approximately USD 505 million in 2024. With a steady growth rate, it is projected to reach USD 790.16 million by 2032, exhibiting a compound annual growth rate (CAGR) of 5.10% during the forecast period. CAGR of 5.10% (2025 – 2032)
By Types:
Hospitals
Home Care
By Applications: Oncology
Gastroenterology
Key players include:
• Fresenius Kabi
• Cardinal Health
• Avanos Medical
• Medline
• Applied Medical Technology
• Moog
• Including or Excluding key companies relevant to your analysis.
